[The treatment of OCD].
Sumitani
Satsuki
S
Department of Psychiatry, University of Tokushima School of Medicine.
Ohmori
Tetsuro
T
D014150:Antipsychotic Agents / Q000627:therapeutic use; D001521:Behavior Therapy / Q000379:methods; D002997:Clomipramine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D016666:Fluvoxamine / Q000627:therapeutic use; D006801:Humans; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use; D009771:Obsessive-Compulsive Disorder / Q000628:therapy*; D017374:Paroxetine / Q000627:therapeutic use; D018967:Risperidone / Q000627:therapeutic use; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*
D014150:Antipsychotic Agents; D002997:Clomipramine; D016666:Fluvoxamine; D008996:Monoamine Oxidase Inhibitors; D017374:Paroxetine; D018967:Risperidone; D017367:Selective Serotonin Reuptake Inhibitors